Technology | June 16, 2015

Apple Introduces ResearchKit Mobile Platform

Open software framework gives medical researchers the tools to improve collection of medical research data

Apple, ResearchKit, open software research, medical research apps

June 16, 2015 - In March, Apple announced the launch of ResearchKit, an open source software framework designed for medical and health research. The platform is designed to help doctors and scientists gather data more frequently and more accurately from participants using iPhone apps. World-class research institutions have already developed apps with ResearchKit for studies on asthma, breast cancer, cardiovascular disease, diabetes and Parkinson's disease. Users decide if they want to participate in a study and how their data is shared.

ResearchKit turns iPhone into a powerful tool for medical research. When granted permission by the user, apps can access data from the Health app such as weight, blood pressure, glucose levels and asthma inhaler use, which are measured by third-party devices and apps. HealthKit is a software framework Apple introduced with iOS 8 to provide developers the ability for health and fitness apps to communicate with each other. ResearchKit can also request access to the accelerometer, microphone, gyroscope and GPS sensors in iPhone to gain insight into a patient's gait, motor impairment, fitness, speech and memory.

ResearchKit also makes it easier to recruit participants for large-scale studies, accessing a broad cross-section of the population - not just those within driving distance of an institution. Study participants can complete tasks or submit surveys right from the app, so researchers spend less time on paperwork and more time analyzing data. ResearchKit also enables researchers to present an interactive informed consent process. Users choose which studies to participate in and the data they want to provide in each study.

"We're excited to use these new ResearchKit tools from Apple to expand participant recruitment and quickly gather even more data through the simple use of an iPhone app. The data it will provide takes us one step closer to developing more personalized care," said Patricia Ganz, M.D., professor at the UCLA Fielding School of Public Health and director of cancer prevention & control research at UCLA's Jonsson Comprehensive Cancer Center. "Access to more diverse patient-reported health data will help us learn more about long-term aftereffects of cancer treatments and provide us with a better understanding of the breast cancer patient experience."

"When it comes to researching how we can better diagnose and prevent disease, numbers are everything. By using Apple's new ResearchKit framework, we're able to extend participation beyond our local community and capture significantly more data to help us understand how asthma works," said Eric Schadt, Ph.D., the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai, and founding director of the Icahn Institute for Genomics and Multiscale Biology. "Using iPhone's advanced sensors, we're able to better model an asthma patient's condition to enable us to deliver a more personalized, more precise treatment."

Developed by the Icahn School of Medicine at Mount Sinai and LifeMap Solutions, the Asthma Health app is designed to facilitate asthma patient education and self-monitoring, promote positive behavioral changes and reinforce adherence to treatment plans according to current asthma guidelines. The study tracks symptom patterns in an individual and potential triggers for these exacerbations so that researchers can learn new ways to personalize asthma treatment.

Other health apps already designed include:

  • The Share the Journey app, developed by the Dana-Farber Cancer Institute, Penn Medicine, Sage Bionetworks and UCLA's Jonsson Comprehensive Cancer Center, is a research study that aims to understand why some breast cancer survivors recover faster than others, why their symptoms vary over time and what can be done to improve symptoms. Share the Journey uses surveys and sensor data on iPhone to collect and track fatigue, mood and cognitive changes, sleep disturbances and reduction in exercise.
  • Developed by Stanford Medicine, the MyHeart Counts app measures activity and uses risk factor and survey information to help researchers more accurately evaluate how a participant's activity and lifestyle relate to cardiovascular health. By studying these relationships on a broad scale, researchers will be able to understand better how to keep hearts healthier.
  • Massachusetts General Hospital developed the GlucoSuccess app to understand how various aspects of a person's life - diet, physical activity and medications - affect blood glucose levels. The app can also help participants identify how their food choices and activity relate to their best glucose levels, enabling them to clearly see correlations and take more active roles in their own well-being.
  • Developed by Sage Bionetworks and the University of Rochester, the Parkinson mPower app helps people living with Parkinson's disease track their symptoms by recording activities using sensors in iPhone. These activities include a memory game, finger tapping, speaking and walking. Activity and survey data from the phone are combined with data from many other participants to fuel Parkinson's research at a scale never before possible, making it the world's largest and most comprehensive study of this disease.


ResearchKit was released as an open source framework in April, providing researchers with the ability to contribute to specific activity modules in the framework, like memory or gait testing, and share them with the global research community to further advance what we know about disease.

ResearchKit apps are available on the App Store.


For more information:

Related Content

What is the cost of interrupting a radiologist?
News | Clinical Study | March 20, 2018
March 20, 2018 – A first of its kind study...
In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows).

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.

News | Prostate Cancer | March 07, 2018
An Italian study featured in the March i
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States
News | Women's Health | March 06, 2018
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer...
dense breast tissue can lead to a missed cancer diagnosis
News | Clinical Study | March 05, 2018
The Athena Breast Health Network has chosen Massachusetts-based Mammosphere to provide network management of medical...
Imaging Plays Key Role in Evaluating Injuries at Olympics
News | Orthopedic Imaging | February 28, 2018
The Olympic Games give elite athletes a chance at athletic triumph, but also carry a risk of injury. When injuries...
ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound
News | Cardiovascular Ultrasound | February 26, 2018
February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are joinin
Agfa Introduces Improved Engage Suite for Integrated Care
News | Patient Engagement | February 16, 2018
At the 2018 Healthcare and Information Management Systems Society annual meeting (HIMSS18), Agfa HealthCare will...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Overlay Init